HolleyPharm Patent Infringement Lawsuit Takes Favorable Turn
This article was originally published in PharmAsia News
Executive Summary
The Patent Re-examination Board of the State Intellectual Property Office of the P.R.C. has given its verdict on the copyright infringement case of Holley Pharmaceuticals (Chongqing) against Chongqing Jianqiao Pharmaceutical Development's product (PharmAsia News, July 28, 2008). SIPO decided that Chongqing Jianqiao's dihydroartemisinin patent lacks creative innovation, thus has ruled in favor of HolleyPharm's subsidiary Beijing Holly-Cotec Pharmaceuticals application for declaring the patent invalid. The judgment will serve as evidence for HolleyPharm's copyright lawsuit appeal to Chongqing Higher People's Court. (Click here for more - Chinese Language)